Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Varsavsky

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Revista Clinica Espanola|June 10, 2014
Vitamin D: present and futureM Varsavsky, G Alonso, A García-Martín
Journal of Endocrinological Investigation|March 7, 2012
Serum osteoprotegerin: bone or cardiovascular marker in Type 2 diabetes males?P Rozas Moreno, R Reyes García, A García-Martín, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 22, 2009
Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analoguesM A Muros, M Varsavsky, P Iglesias Rozas, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 2, 2013
Sclerostin serum levels in prostate cancer patients and their relationship with sex steroidsB García-Fontana, S Morales-Santana, M Varsavsky, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 17, 2012
SHBG levels are associated with bone loss and vertebral fractures in patients with prostate cancerM Varsavsky, R Reyes-García, A García-Martín, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Revista Clinica Espanola|June 10, 2014
Vitamin D: present and futureM Varsavsky, G Alonso, A García-Martín
Journal of Endocrinological Investigation|March 7, 2012
Serum osteoprotegerin: bone or cardiovascular marker in Type 2 diabetes males?P Rozas Moreno, R Reyes García, A García-Martín, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 22, 2009
Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analoguesM A Muros, M Varsavsky, P Iglesias Rozas, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 2, 2013
Sclerostin serum levels in prostate cancer patients and their relationship with sex steroidsB García-Fontana, S Morales-Santana, M Varsavsky, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 17, 2012
SHBG levels are associated with bone loss and vertebral fractures in patients with prostate cancerM Varsavsky, R Reyes-García, A García-Martín, et al.
Pageof 1